A Study of Depemokimab in Participants of 6 to 11 Years of Age

NCT07671001 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
34
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline